[Table/Fig-4]:
Treatment parameters and outcome of bilateral breast cancer
| Variable | Synchronous(n=28) | Metachronous(n=2) |
|---|---|---|
| SURGERY PERFORMED | ||
| Bil. Mastectomy (n=24) | 22 | 2 |
| Bil. MRM | 12 | 0 |
| U/L MRM and C/L Mast.+SLNB | 5 | 1 |
| Bil. Mast +SLNB | 3 | 1 |
| Bilateral BCS (n=4) | 4 | 0 |
| U/L BCS+ C/ L Mastectomy (n=2) | 1 | 1 |
| NACT | 6 | 0 |
| Adj.Chemo | 9 | 1 |
| Adj.RT | 13 | 0 |
| (i)Bilateral Radiation (n=11) | 11 | 0 |
| Bilateral CW alone | 1 | 0 |
| Bilateral CW+ RN* | 4 | 0 |
| CW+ Breast | 2 | 0 |
| Bil. Whole Breast | 4 | 0 |
| (ii)Unilateral CW radiation (n=2) | 2 | 0 |
| Adj. Hormone Therapy | 21 | 2 |
| Adj. Trastuzumab | 2 | 0 |
| Complications | ||
| Lymphedema | 4 | 0 |
| Outcomes | ||
| Death Due to disease | 1 | 1 |
| Systemic and local recurrence | 2 | 0 |
| Alive and disease Free | 25 | 1 |
*- RN-Regional nodal irradiation included radiation to axilla and supraclavicular areas